We observed that both compounds readily induced BRG1 as well as reduced GSK3β phosphorylation (Figure 4C and 4D), and inhibited the growth of Sum159 and DT13, two BRG1- deficient breast cancer cell lines (Figure 4A and 4B). Here, SMARCA4 is linked to breast cancer.